Showing results (371-380 of 425) with videos related to

Sort By:
Pageof 43
Frontiers in Neurology|July 19, 2021
Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of CareBrent Bluett, Alexander Y Pantelyat, Irene Litvan, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|April 15, 2021
Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementiaMegan S Barker, Masood Manoochehri, Sandra J Rizer, et al.
Brain Communications|May 24, 2024
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's diseaseLeonardo Iaccarino, Jorge J Llibre-Guerra, Eric McDade, et al.
Cell Reports. Medicine|May 2, 2022
Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disordersTania F Gendron, Michael G Heckman, Launia J White, et al.
The Journal of Prevention of Alzheimer'S Disease|January 25, 2026
Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degenerationJesús García-Castro, Lawren VandeVrede, Michael C Donohue, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2019
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsyMax-Joseph Grimm, Gesine Respondek, Maria Stamelou, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 23, 2018
Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathologyRenaud La Joie, Nagehan Ayakta, William W Seeley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 16, 2012
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)Adam L Boxer, Michael Gold, Edward Huey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2024
Psychotropic medication usage in sporadic versus genetic behavioral-variant frontotemporal dementiaJuan-Camilo Vargas-Gonzalez, Nico Dimal, Kasey Cortez, et al.
Neurology|July 5, 2022
Differences in Motor Features of C9orf72, MAPT, or GRN Variant Carriers With Familial Frontotemporal Lobar DegenerationPhilip Wade Tipton, Angela B Deutschlaender, Rodolfo Savica, et al.
Pageof 43